Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Update

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 36,800 shares, an increase of 1,500.0% from the December 31st total of 2,300 shares. Based on an average daily volume of 214,500 shares, the short-interest ratio is presently 0.2 days.

Chugai Pharmaceutical Price Performance

CHGCY opened at $20.33 on Thursday. The firm has a fifty day moving average price of $21.62 and a 200 day moving average price of $22.45. Chugai Pharmaceutical has a 1 year low of $14.52 and a 1 year high of $26.00. The stock has a market cap of $66.91 billion, a P/E ratio of 26.06 and a beta of 0.81.

Chugai Pharmaceutical Company Profile

Chugai Pharmaceutical Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company’s products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.